参考文献 (References)[1] N. Cervoni, M. Szyf. Demethylase activity is directed by histone acetylation. The Journal of Biological Chemistry, 2001, 276(44): 40778-40787.
[2] N. Detich, J. Theberge and M. Szyf. Promoter-specific activation and demethylation by MBD2/demethylase. The Journal of Biological Chemistry, 2002, 277(39): 35791-35794.
[3] D. Bruniquel, R. H. Schwartz. Selective, stable demethylation of the interleukin-2 gene enhances transcription by an active process. Nature Immunology, 2003, 4(3): 235-240.
[4] K. Martinowich, D. Hattori, H. Wu, et al. DNA methylationrelated chromatin remodeling in activity-dependent BDNF gene regulation. Science, 2003, 302(5646): 890-893.
[5] I. C. Weaver, N. Cervoni, F. A. Champagne, et al. Epigenetic programming by maternal behavior. Nature Neuroscience, 2004, 7(8): 847-854.
[6] M. J. Meaney, M. Szyf. Maternal care as a model for experience-dependent chromatin plasticity? Trends Neuroscience, 2005, 28(9): 456-463.
[7] N. Tsankova, W. Renthal, A. Kumar, et al. Epigenetic regulation in psychiatric disorders. Nature Reviews Neuroscience, 2007, 8(5): 355-367.
[8] A. Razin, S. Razin. Methylated bases in mycoplasmal DNA. Nucleic Acids Research, 1980, 8(6): 1383-1390.
[9] M. Comb, H. M. Goodman. CpG methylation inhibits proenkephalin gene expression and binding of the transcription factor AP-2. Nucleic Acids Research, 1990, 18(13): 3975-3982.
[10] T. Jenuwein, C. D. Allis. Translating the histone code. Science, 2001, 293(5532): 1074-1080.
[11] M. Szyf. DNA methylation and demethylation as targets for anticancer therapy. Biochemistry (Mosc), 2005, 70(5): 533-549.
[12] D. A. Regier, J. H. Boyd, J. D. Burke, et al. One-month prevalence of mental disorders in the United States. Based on five Epidemiologic Catchment Area sites. Archives of General Psychiatry, 1988, 45(11): 977-986.
[13] R. C. Kessler, W. T. Chiu, O. Demler, et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the national comorbidity survey replication. Archives of General Psychiatry 2005, 62(6): 617-627.
[14] A. D. Lopez, C. C. Murray. The global burden of disease, 1990-2020. Nature Medicine 1998, 4(11): 1241-1243.
[15] S. M. Monroe, A. D. Simons and M. E. Thase. Onset of depression and time to treatment entry: Roles of life stress. Journal of Consulting and Clinical Psychology, 1991, 59(4): 566-573.
[16] K. S. Kendler, R. C. Kessler, E. E. Walters, et al. Stressful life events, genetic liability, and onset of an episode of major depression in women. American Journal of Psychiatry, 1995, 152(6): 833-842.
[17] E. Castren. Neurotrophic effects of antidepressant drugs. Current Opinion in Pharmacology, 2004, 4(1): 58-64.
[18] E. Castren, V. Voikar and T. Rantamaki. Role of neurotrophic factors in depression. Current Opinion in Pharmacology, 2007, 7(1): 18-21.
[19] P. J. Cowen. Serotonin and depression: Pathophysiological mechanism or marketing myth? Trends in Pharmacological Sciences, 2008, 29(9): 433-436.
[20] A. Caspi, K. Sugden, T. E. Moffitt, et al. Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene. Science, 2003, 301(5631): 386-389.
[21] P. G. Surtees, N. W. Wainwright, S. A. Willis-Owen, et al. Social adversity, the serotonin transporter (5-HTTLPR) polymorphism and major depressive disorder. Biological Psychiatry, 2006, 59(3): 224-229.
[22] T. Canli, M. Qiu, K. Omura, et al. Neural correlates of epigenesis. Proceedings of the National Academy of Sciences USA, 2006, 103(43): 16033-16038.
[23] P. E. Bebbington, D. Bhugra, T. Brugha, et al. Psychosis, victimisation and childhood disadvantage: evidence from the second. British National Survey of Psychiatric Morbidity, 2004, 185: 220-226.
[24] A. Kaffman, M. J. Meaney. Neurodevelopmental sequelae of postnatal maternal care in rodents: clinical and research implications of molecular insights. The Journal of Child Psychology and Psychiatry, 2007, 48(3-4): 224-244.
[25] P. E. Mullen, J. L. Martin, J. C. Anderson, et al. The long-term impact of the physical, emotional, and sexual abuse of children: A community study. Child Abuse & Neglect, 1996, 20(1): 7-21.
[26] D. Maestripieri. The biology of human parenting: Insights from nonhuman primates. Neuroscience & Biobehavioral Reviews, 1999, 23(3): 411-422.
[27] D. Maestripieri. Early experience affects the intergenerational transmission of infant abuse in rhesus monkeys. Proceedings of National Academy Science USA, 2005, 102(27): 9726-9729.
[28] M. M. Sanchez. The impact of early adverse care on HPA axis development: Nonhuman primate models. Hormones and Behavior, 2006, 50(4): 623-631.
[29] C. Murgatroyd, A. V. Patchev, Y. Wu, et al. Dynamic DNA methylation programs persistent adverse effects of early-life stress. Nature Neuroscience, 2009, 12(12): 1559-1566.
[30] P. O. McGowan, A. Sasaki, A. C. D’Alessio, et al. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nature Neuroscience, 2009, 12(3): 342- 348.
[31] M. J. Webster, M. B. Knable, J. O’Grady, et al. Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders. Molecular Psychiatry, 2002, 7(9): 985-994, 924.
[32] J. Y. Lau, T. C. Eley. The genetics of mood disorders. Annual Reviews of Clinical Psychology, 2010, 6: 313-337.
[33] C. Caldji, B. Tannenbaum, S Sharma, et al. Maternal care during infancy regulates the development of neural systems mediating the expression of fearfulness in the rat. Proceeding of National Academy Science USA, 1998, 95(9): 5335-5340.
[34] D. Francis, J. Diorio, D. Liu, et al. Nongenomic transmission across generations of maternal behavior and stress responses in the rat. Science, 1999, 286(5442): 1155-1158.
[35] J. A. McCormick, V. Lyons, M. D. Jacobson, et al. 5'-heterogeneity of glucocorticoid receptor messenger RNA is tissue specific: Differential regulation of variant transcripts by early-life events. Molecular Endocrinology, 2000, 14(4): 506-517.
[36] W. M. Daniels, L. R. Fairbairn, G. van Tilburg, et al. Maternal separation alters nerve growth factor and corticosterone levels but not the DNA methylation status of the exon 1(7) glucocorticoid receptor promoter region. Metabolic Brain Disease, 2009, 24(4): 615-627.
[37] M. J. Meaney, D. H. Aitken, V. Viau, et al. Neonatal handling alters adrenocortical negative feedback sensitivity and hippocampal type II glucocorticoid receptor binding in the rat. Neuroendocrinology, 1989, 50(5): 597-604.
[38] I. C. Weaver, F A. Champagne, S. E. Brown, et al. Reversal of maternal programming of stress responses in adult offspring through methyl supplementation: Altering epigenetic marking later in life. Journal of Neuroscience, 2005, 25(47): 11045-11054.
[39] S. E. Hyman. Even chromatin gets the blues. Nature Neuroscience, 2006, 9(4): 465-466.
[40] M. G. Lee, C. Wynder, D. M. Schmidt, D. G. McCafferty and R. Shiekhattar. Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications. Chemistry & Biology, 2006, 13(6): 563-567.
[41] N. M. Tsankova, A. Kumar and E. J. Nestler. Histone modifications at gene promoter regions in rat hippocampus after acute and chronic electroconvulsive seizures. Journal of Neuroscience, 2004, 24(24): 5603-5610.
[42] N. M. Tsankova, O. Berton, W. Renthal, et al. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nature Neuroscience, 2006, 9(4): 519- 525.